期刊文献+

血培养鲍曼不动杆菌阳性的临床分析 被引量:2

在线阅读 下载PDF
导出
摘要 目的调查鲍曼不动杆菌引起的菌血症的临床分布特征和耐药性特点。方法回顾性临床研究分析2004年3月至2004年12月住院病人血液中分离的鲍曼不动杆菌的临床资料,并用Whonet5.3软件对鲍曼不动杆菌的药敏进行统计分析。结果所有送检病人中有31例血液培养出鲍曼不动杆菌,有8例(25.8%)是污染,其余23例(74.2%)确定为菌血症,主要分布在肝移植病房和ICU,死于鲍曼不动杆菌菌血症的有7例(30.4%),1例未愈,15例(65.2%)治愈。鲍曼不动杆菌对多种抗菌药物耐药,对亚胺培南、哌拉西林/他唑巴坦、头孢哌酮/舒巴坦的耐药率分别为55.6%、44.4%、42.6%的高耐药率。结论由于病人基础疾病严重,住院时间长,呼吸机、免疫抑制剂的使用,各种导管和侵入性操作是感染血液的危险因素,广谱抗生素的大量使用产生了多重耐药菌株,增加了患者的危险性,提示应高度重视并积极采取相应的防范措施,控制该菌耐药率的上升和多重耐药菌株的产生,预防医院感染。
出处 《江西医学检验》 2006年第1期37-38,共2页 Jiangxi Journal of Medical Laboratory Sciences
  • 相关文献

参考文献8

  • 1Bou G,Oliver A,Martrinez J,et al.OXA-24,a novel class Acineto-bacter baumannii clinical strain[J].Antimicrob Agents Chemother,2000,44(6):1556 ~ 1561.
  • 2Bergogne-Berezin E,Towner KJ.Acinetobacter spp.as nosocomial pathogens:microbiological,clinical,and epidemiological features[J].Clin Microbiol Rev 1996,9:148 ~ 165.
  • 3王辉,张悦娴,谢秀丽,徐英春,陈民钧.血培养凝固酶阴性葡萄球菌阳性的临床意义[J].中国抗感染化疗杂志,2001,1(2):79-82. 被引量:79
  • 4Scerpella E G,Wanger A R,Armitige L,et al.Nosocomial outbreak caused by 9 multiresistance clone of Acinetobacter baumannii; results of the case control and molecular epide miologic investigations[J].Infect Control Hosp Epidemiol,1995,16(2):59 ~ 62.
  • 5Wisplinghoff H,Perbix W,Seifert H.Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii:a case-control study of adult burn patients[J].Clin Infect,Dis 1999,139:371 ~ 375.
  • 6Cisneros JM,Reyes M J,Pachon J,et al.Bacteremia due to Acietobacter baumannii:epidemiology,clinical findings and prognostic features[J].Clin Infect Dis 1996,22:1026 ~ 1032.
  • 7Siau H,Yuen KY,Ho PL,et al.Acinetobacter bacteremia in Hong Kong:prospective study and review[J].Clin Infect Dis 1999,28:26 ~30.
  • 8吴劲松,卢月梅,吴伟元,何林,余涟,钱春莲.鲍曼不动杆菌的感染分布及耐药性分析[J].中国感染控制杂志,2004,3(3):247-249. 被引量:27

二级参考文献20

  • 1[1]Bou G, Oliver A, Martrinez J, et al. OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain[J]. Antimicrob Agents Chemother, 2000, 44(6): 1556-1561.
  • 2[2]Iregbu K C, Ogunsola F T, Odugbemi T O. Infections caused by Acinetobacter species and their susceptibility to 14 antibiotics in Lagos University Teaching Hospital, Lagos[J]. West Afr J med, 2002, 21(3): 226-229.
  • 3[3]Scerpella E G, Wanger A R, Armitige L, et al. Nosocomial outbreak caused by 9 multiresistance clone of Acinetobacter baumannii; results of the case control and molecular epidemiologic investigations[J]. Infect Control Hosp Epidemiol, 1995, 16(2): 92-97.
  • 4[5]Fernandez-Cuenca F, Martinez-Martinez L, Conejo MC, et al. Relationship between beta-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii[J]. J Antimicrob Chemother, 2003, 51(3): 565-74.
  • 5[6]Gales A C, Tognim M C, Reis A O, et al. Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital[J]. Diagn Microbiol Infect Dis, 2003, 45(1): 77-79.
  • 6[8]Rodriguez-Bano J, Pascual A, Gavez J, et al. Acinetobacter baumannii bacteremia: clinical and prognostic features[J]. Enferm Infect Microbiol Clin, 2003, 21(5): 242-277.
  • 7Jones RN. Impact of changing pathogens and antimicrobial susceptibility patterns inthe treatment of serious infections in hospitalized patients[J]. Am J Med, 1996, 100 (6A):3S-12S.
  • 8徐英春 谢秀丽 张小江 等.从血及无菌体液中分离的669株细菌分析[J].中华微生物学和免疫学杂志,1996,16(2):4-7.
  • 9Chandrasekar PH,Brown WJ. Clinical issues of blood cultures[J]. Arch Intern Med,1994, 154(4): 841-849.
  • 10Khatib R, Riederer KM, Clark JC, et al. Coagulase-negative staphylococci inmultiple blood cultures: strain relatedness and determinants of same-strain bacteremia[J].J Clin Microbiol, 1995, 33(4): 816-820.

共引文献104

同被引文献8

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部